ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

In Brief: James Institute Receives $9 Million Gift; NCI’s Fraumeni Wins Public Health Award

November 3, 1995

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

RFA On Hepatitis B Virus, Liver Cancer

April 15, 1983